Global private equity and venture capital news and research

Bay City Capital leads $42m round for Dermira

21 Oct 2011

Growth investors including Bay City Capital have raised $42m in a Series A financing round for Dermira, in a deal which will fund the dermatology group’s acquisition of Canadian rival Valocor Therapeutics

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016